HPV genotype distribution and anomalous association of HPV33 to cervical neoplastic lesions in San Luis Potosi, Mexico

被引:12
作者
DelaRosa-Martinez, Raul [1 ]
Sanchez-Garza, Mireya [1 ]
Lopez-Revilla, Ruben [1 ]
机构
[1] Inst Potosino Invest Cient & Tecnol, Div Biol Mol, Camino Presa San Jose 2055, San Luis Potosi 78216, Slp, Mexico
来源
INFECTIOUS AGENTS AND CANCER | 2016年 / 11卷
关键词
Cervical cancer; Human papillomavirus; Atypical squamous cells of undetermined significance; Low-grade squamous intraepithelial lesions; High-grade squamous intraepithelial lesions; Invasive cervical carcinoma; HPV33; outbreak; HUMAN-PAPILLOMAVIRUS TYPES; INTRAEPITHELIAL NEOPLASIA; CANCER; PREVALENCE; WOMEN; INFECTION; WORLDWIDE; DNA; CLASSIFICATION; GUANACASTE;
D O I
10.1186/s13027-016-0063-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The association of human papillomavirus (HPV) types to neoplastic lesions increase as a function of their oncogenicity and the duration of the infection since lesion severity progresses from low-grade to high-grade and cancer. In an outbreak, the prevalence of the HPV type involved would increase and the proportion of the associated low-grade lesions would predominate over severe lesions. In this study, the prevalence of HPV types and their association to neoplastic lesions was determined in women subjected to colposcopy in San Luis Potosi, Mexico. Methods: DNA from high-risk (HR) and low-risk (LR) HPV types was identified by E6 nested multiplex PCR in cervical scrapes from 700 women with normal cytology, atypical squamous cells of undetermined significance (ASCUS), low-grade squamous intraepithelial lesions (LSIL), high-grade squamous intraepithelial lesions (HSIL) or invasive cervical cancer (CC). Results: Overall HPV-DNA prevalence was 67.7 %, that of HR-HPV was 63.1 %, and that of LR-HPV was 21.3 %. The highest prevalence (78.2 %) occurred in the 15-24 year group, whereas that of single infections was 52 % and that of multiple infections (i.e., by 2-6 HPV types) was 48 %. The most prevalent HR types were HPV33 (33.1 %), HPV16 (16.6 %), HPV18 and HPV51 (6.7 % each). HR-HPV prevalence was 29.6 % in normal cytology, 26.7 % in ASCUS, 63.3 % in LSIL, 68.2 % in HSIL, and 90.5 % in CC. Three prevalence trends for HR-HPV types were found in neoplastic lesions of increasing severity: increasing (LSIL < HSIL < CC) for HPV16, HPV39, HPV18, HPV58, HPV31 and HPV35; asymptotic (LSIL < HSIL approximate to CC) for HPV51 and HPV68; U-shaped (LSIL < HSIL > CC) for HPV33. Conclusions: Two-thirds of the women subjected to colposcopy from 2007 to 2010 in San Luis Potosi have HPV infections which predominate in the 15-24 years group. Around half of the infections are by one viral type and the rest by 2-6 types. HPV33 is the most prevalent type, followed by HPV16. Overall HR-HPV prevalence increases with the severity of neoplastic lesions. HPV33 prevalence is highest in LSIL and its U-shaped trend with progressing neoplastic lesions differs from the growing/asymptotic trends of other HR-HPV types. An ongoing or recent HPV33 outbreak is consistent with its high prevalence and anomalous association to LSIL.
引用
收藏
页数:10
相关论文
共 38 条
  • [11] Classification of papillomaviruses
    de Villiers, EM
    Fauquet, C
    Broker, TR
    Bernard, HU
    zur Hausen, H
    [J]. VIROLOGY, 2004, 324 (01) : 17 - 27
  • [12] Dean A.G., 2011, OPENEPI OPEN SOURCE
  • [13] Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
    Ferlay, Jacques
    Shin, Hai-Rim
    Bray, Freddie
    Forman, David
    Mathers, Colin
    Parkin, Donald Maxwell
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (12) : 2893 - 2917
  • [14] Variations in the age-specific curves of human papillomavirus prevalence in women worldwide
    Franceschi, Silvia
    Herrero, Rolando
    Clifford, Gary M.
    Snijders, Peter J. F.
    Arslan, Annie
    Anh, Pham Thi Hoang
    Bosch, F. Xavier
    Ferreccio, Catterina
    Hieu, Nguyen Trong
    Lazcano-Ponce, Eduardo
    Matos, Elena
    Molano, Monica
    Qiao, You-Lin
    Rajkumar, Raj
    Ronco, Guglielmo
    de Sanjose, Silvia
    Shin, Hai-Rim
    Sukvirach, Sukhon
    Thomas, Jaiye O.
    Meijer, Chris J. L. M.
    Munoz, Nubia
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (11) : 2677 - 2684
  • [15] Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica
    Herrero, R
    Castle, PE
    Schiffman, M
    Bratti, MC
    Hildesheim, A
    Morales, J
    Alfaro, M
    Sherman, ME
    Wacholder, S
    Chen, S
    Rodriguez, AC
    Burk, RD
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (11) : 1796 - 1807
  • [16] IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007, IARC Monogr Eval Carcinog Risks Hum, V90, P1
  • [17] Prevalence and distribution of human papillomavirus types in cervical cancer, squamous intraepithelial lesions, and with no intraepithelial lesions in women from Southern Mexico
    Illades-Aguiar, Berenice
    del Carmen Alarcon-Romero, Luz
    Antonio-Vejar, Veronica
    Zamudio-Lopez, Noelio
    Sales-Linares, Natividad
    Flores-Alfaro, Eugenia
    Fernandez-Tilapa, Gloria
    Vences-Velazquez, Amalia
    Francisco Munoz-Valle, Jose
    Leyva-Vazquez, Marco-Antonio
    [J]. GYNECOLOGIC ONCOLOGY, 2010, 117 (02) : 291 - 296
  • [18] Burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease
    Lacey, Charles J. N.
    Lowndes, Catherine M.
    Shah, Keerti V.
    [J]. VACCINE, 2006, 24 : 35 - 41
  • [19] Lazcano-Ponce E, 2001, INT J CANCER, V91, P412, DOI 10.1002/1097-0215(20010201)91:3<412::AID-IJC1071>3.0.CO
  • [20] 2-M